Dehydration (Physiology) Completed Phase 4 Trials for Hyaluronidase (human recombinant) (DB06205)

Also known as: Dehydration / Fluid volume deficit (finding) / Exsiccosis / Dehydration (disorder)

IndicationStatusPhase
DBCOND0116068 (Dehydration (Physiology))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00477152Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and ChildrenTreatment
NCT00773175Subcutaneous Rehydration Compared to Intravenous RehydrationTreatment
NCT00807885Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant HyaluronidaseTreatment